Market Tracker

05/26 5:16pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.4523
Delayed Data
As of 3:59pm ET
 -0.058 / -11.37%
Today’s Change
0.39
Today|||52-Week Range
6.49
-84.67%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close0.51
Today’s open0.52
Day’s range0.41 - 0.52
Volume11,039,615
Average volume (3 months)2,863,705
Market cap$31.2M
Dividend yield--
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+44.24%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
EYEGEyeGate Pharmaceutic...-0.09-2.41%
ABIOARCA Biopharma Inc-0.02-0.60%
OGXIOncoGenex Pharmaceut...-0.02-1.96%
THLDThreshold Pharmaceut...-0.00-0.58%
Data as of 3:59pm ET, 05/26/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Operating Officer
Terence S. Novak
Chief Financial Officer &
Head-Investor Relations
Sanjay S. Patel
Corporate headquarters
Morristown, New Jersey

Forecasts